wegovy or tirzepatide Zepbound beats for weight loss in first head-to-head trial of blockbuster drugs – Tirzepatide Vs. Wegovy®: Drug Comparison

In a significant milestone for type 2 diabetes care, Novo Nordisk has unveiled full results from its SOUL cardiovascular outcomes trial, confirming that oral semaglutide (14 mg) reduces the risk of major adverse cardiovascular events (MACE) by 14 per cent compared to placebo in adults with type 2 diabetes and existing cardiovascular and/or chronic kidney disease

When to call a professional Contact your doctor for a physical examination if you experience unexplained fatigue, palpitations, shortness of breath, sore tongue, or any other symptoms of vitamin B 12 deficiency

PKM2, M2 isoform of pyruvate kinase

Associations of plasma glucagon levels with estimated glomerular filtration rate, albuminuria and diabetic kidney disease in patients with type 2 diabetes mellitus